The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial

Aging and osteoporosis in breast and prostate cancer

(2011) Ari VanderWalde et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) S. Aebi et al.   ANNALS OF ONCOLOGY

Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial

(2010) R. Eastell et al.   ANNALS OF ONCOLOGY

Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study

(2010) Robert E. Coleman et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen

(2008) Paul E. Goss et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

(2008) Richard Eastell et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

(2008) Michael Gnant et al.   LANCET ONCOLOGY